Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by TheeRookon Jan 25, 2021 1:58pm
124 Views
Post# 32377095

RE:RE:RE:RE:👍 AWESOME NEWS 💥

RE:RE:RE:RE:👍 AWESOME NEWS 💥  Getting calls from CROs  .  Hey THRM heard your looking for some testing to be done.
US $300,000 gets U 30 postivies and there are plenty of those.  When do U want to start.

Hmm letss see maybe in FEB .  We do not have any tests available.  Also do not have any money do U take shares for Debt.


Therma Bright also announces that it has negotiated debt settlements with arm's-length creditors. Pursuant to the debt settlement agreements, and subject to acceptance by the TSX Venture Exchange, the company has agreed to settle aggregate outstanding debt of $65,250 in consideration for which it will issue an aggregate of 145,000 common shares at a deemed price of 45 cents per share. All shares issued in relation to these debt settlements are subject to a hold period expiring four months plus one day after the date the shares are issued, 




Euro007 wrote: @ThreeRook, therma Bright would do all the contracts/business: we are pleased to have received significant interest from overseas facilities in the UK, the US and in addition to the Province of Ontario, other provinces in Canada". Read more at: https://www.newsfilecorp.com/release/72711/Therma-Bright-Acquires-100-Control-of-its-COVID19-Rapid-Saliva-Antigen-Test-and-Announces-Proposed-Name-Change-for-the-Test
TheeRook wrote:  There are NO brains to develop the test at THRM,   Its all done by nanoCompsix.
If any company gets bought out its nanoComposix.


 Therma Bright, commented: "We are pleased to complete the feasibility study and advance to next steps in the development of CoviSafe. It is exciting to work with such a pro-active and experienced team at nanoComposix. nanoComposix will assist Therma and Orpheus to fast-track the development of CoviSafe."


nrv090909 wrote: Like I said, buyout is coming folks. Mark it. Johnson and Johnson can turn this real quick. Regardless, $1 coming real soon.

 




<< Previous
Bullboard Posts
Next >>